Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. PIMA541982

Invitrogen™ Modotuximab Chimeric Recombinant Human Monoclonal Antibody

Human Recombinant Monoclonal Antibody

Supplier:  Invitrogen™ MA541982

Catalog No. PIMA541982


Only null left
Add to Cart
This item is not returnable. View return policy

Description

Description

Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week. Store at -20 to -80 °C for twelve months from the date of receipt.

Modotuximab is under investigation in clinical trial NCT03549338 (Sym004 Versus Futuximab or Modotuximab in Patients With mCRC).
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Modotuximab Chimeric
Recombinant Monoclonal
Unconjugated
DS 1024; ERBB1 domain III; Sym 004 (combination of modotuximab and futuximab)
Human EGFR/ERBB1 domain III.
100 μg
Primary
-20°C, Avoid Freeze/Thaw Cycles
Liquid
Chemical
ELISA, SDS-Page
1 mg/mL
PBS with no preservative; pH 7.4
Human
Protein A
RUO
Human
Antibody
IgG1 κ
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.